Last kr266.00 DKK
Change Today -0.50 / -0.19%
Volume 4.1M
NOVOB On Other Exchanges
Symbol
Exchange
OTC US
Copenhagen
New York
Mexico
Frankfurt
Frankfurt
As of 11:01 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Lars Fruergaard Jørgensen

Chief Information Officer, Executive Vice President and Member of Executive Management, Novo Nordisk A/S
AgeTotal Calculated CompensationThis person is connected to 14 board members in 3 different organizations across 5 different industries.

See Board Relationships
48kr7,200,000
As of Fiscal Year 2013

Background*

Mr. Lars Fruergaard Jørgensen has been the Chief Information Officer and Executive Vice President at Novo Nordisk A/S since January 2013 and serves as Member of Executive Management. Mr. Jørgensen served as Head of IT & Corporate Development at Novo Nordisk A/S from 2004 to January 31, 2013. Mr. Jørgensen joined Novo Nordisk in 1991 as an economist in Health Care, Economy & Planning and has over the years completed overseas postings in the US and Japan. Since 2004, he ...

Read Full Background

Corporate Headquarters*

Novo Allé
Bagsvaerd, Capital Region of Denmark 2880

Denmark

Phone: 45 44 44 88 88
Fax: 45 44 49 05 55

Board Members Memberships*

Vice Chairman
Director
2005-Present
Director
2010-2010
Former Director

Education*

MS 1991
Aarhus Business School

Other Affiliations*

Annual Compensation*

Salarykr4,100,000
Bonuskr1,400,000
Total Annual Compensationkr5,500,000

Stock Options*

All Other Compensationkr1,700,000

Total Compensation*

Total Annual Cash Compensationkr7,200,000
Total Short Term Compensationkr5,500,000
Other Long Term Compensationkr1,700,000
Total Calculated Compensationkr7,200,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVOB:DC kr266.00 DKK -0.50

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Rakesh Kapoor Chief Executive Officer, Executive Director and Member of Nomination Committee
Reckitt Benckiser Group plc
4.4M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO NORDISK A/S-B, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.